Xu Cheryl's Form 4 filing
60 Degrees Pharmaceuticals, Inc. (SXTP) · filed Jun 5, 2025
- Accession no.
- 0001213900-25-051700
- Filed
- Jun 5, 2025
- Trade date
- Jun 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $14.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xu CherylCIK 0001976957 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Common Stock | PPurchaseAcquired | +3,000 | $2.87 | +$8,610 | 13,816 | Direct | |
| Jun 3, 2025 | Common Stock | PPurchaseAcquired | +2,000 | $2.90 | +$5,800 | 15,816 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.